Virulence factors of gram-negative bacteria in sepsis with a focus on Neisseria meningitidis

Contributions to Microbiology

Volumn 17, Issue , 2011, Pages 31-47

  Livorsi, Daniel J ^a   Stenehjem, Edward ^a   Stephens, David S ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; VIRULENCE FACTOR;

ARTICLE; BACTERIUM ADHERENCE; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HUMAN; IMMUNE EVASION; LOCOMOTION; METABOLISM; MICROBIOLOGY; NEISSERIA MENINGITIDIS; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; SEPSIS; VIRULENCE;

BACTERIAL ADHESION; BACTERIAL TOXINS; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; IMMUNE EVASION; LOCOMOTION; NEISSERIA MENINGITIDIS; SEPSIS; VIRULENCE; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; NEISSERIA MENINGITIDIS;

EID: 84926099176     PISSN: 14209519     EISSN: 1662291X     Source Type: Book Series    
DOI: 10.1159/000324008     Document Type: Article

References (44)

1. Hodgin KE, Moss M: The epidemiology of sepsis. Curr Pharm Des 2008;14:1833-1839.
2. Tzeng YL, Stephens DS: Epidemiology and pathogenesis of Neisseria meningitidis. Microbes Infect 2000;2:687-700.
3. Stephens DS, Greenwood B, Brandtzaeg P: Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 2007;369:2196-2210.
4. Mattick JS: Type IV pili and twitching motility. Ann Rev Microbiol 2002;56:289-314.
5. Hill DJ, Griffiths NJ, Borodina E, Virji M: Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease. Clin Sci (Lond) 2010;118:547-564.
6. Harshey RM: Bacterial motility on a surface: Many ways to a common goal. Ann Rev Microbiol 2003;57: 249-273.
7. Feldman M, Bryan R, Rajan S, Scheffler L, Brunnert S, Tang H, Prince A: Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection. Infect Immun 1998;66:43-51.
8. Suffredini AF, Hochstein HD, McMahon FG: Dose-related inflammatory effects of intravenous endotoxin in humans: Evaluation of a new clinical lot of Escherichia coli O:113 Endotoxin. J Infect Dis 1999;179:1278-1282.
9. Brandtzaeg P, Kierulf P, Gaustad P, Skulberg A, Bruun JN, Halvorsen S, Sorensen E: Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 1989;159:195-204.
10. Lo H, Tang CM, Exley RM: Mechanisms of avoidance of host immunity by Neisseria meningitidis and its effect on vaccine development. Lancet Infect Dis 2009;9:418-427.
11. Gunn JS, Ernst RK: The structure and function of Francisella lipopolysaccharide. Ann NY Acad Sci 2007;1105;202-218.
12. Trent MS, Stead CM, Tran AX, Hankins JV: Diversity of endotoxin and its impact on pathogenesis. J Endotox Res 2006;12:205-223.
13. Ophir T, Gutnick DL: A Role for Exopolysaccharides in the protection of microorganisms from desiccation. Appl Environ Microbiol 1994;60:740-745.
14. Taylor CM, Roberts IS: Capsular polysaccharides and their role in virulence. Contrib Microbiol 2005; 12:55-66.
15. Yoshida K, Matsumoto T, Tateda K, Uchida K, Tsujimoto S, Yamaguchi K: Induction of interleukin-10 and down-regulation of cytokine production by Klebsiella pneumoniae capsule in mice with pulmonary infection. J Med Microbiol 2001;50: 456-461.
16. Hoffman JA, Wass C, Stins MF, Kim KS: The capsule supports survival but not traversal of Escherichia coli K1 across the blood-brain barrier. Infect Immun 1999;67:3566-3570.
17. Buckles EL, Wang X, Lane MC, Lockatell CV, Johnson DE, Rasko DA, Mobley HL, Donnenberg MS: Role of the K2 capsule in Escherichia coli urinary tract infection and serum resistance. J Infect Dis 2009;199:1689-1697.
18. Schneider G, Dobrindt U, Bruggemann H, Nagy G, Janke B, Blum-Oehler G, Buchrieser C, Gottschalk G, Emody L, Hacker J: The pathogenicity islandassociated K15 capsule determinant exhibits a novel genetic structure and correlates with virulence in uropathogenic Escherichia coli strain 536. Infect Immun 2004;72:5993-6001.
19. Potempa J, Pike RN: Bacterial peptidases. Contrib Microbiol. Basel, Karger, 2005, vol 12, pp 132-180.
20. Haiko J, Suomalainen M, Ojala T, Lahteenmaki K, Korhonen TK: Breaking barriers-attack on innate immune defences by omptin surface proteases of enterobacterial pathogens. Innate Immun 2009;15: 67-80.
21. Adler NR, Govan B, Cullinane M, Harper M, Adler B, Boyce JD: The molecular and cellular basis of pathogenesis in melioidosis: How does Burkholderia pseudomallei cause disease? FEMS Microbiol Rev 2009;33:1079-1099.
22. Pujol C, Bliska JB: Turning Yersinia pathogenesis outside in: Subversion of macrophage function by intracellular Yersiniae. Clin Immunol 2005;114: 216-226.
23. Payne SM: Iron acquisition in microbial pathogenesis. Trends Microbiol 1993;1:66-69.
24. Schryvers AB, Stojiljkovic I: Iron acquisition systems in the pathogenic Neisseria. Mol Microbiol 1999;32: 1117-1123.
25. Beier D, Gross R: Regulation of bacterial virulence by two-component systems. Curr Opin Microbiol 2006;9:143-152.
26. Krukonis ES, DiRita VJ: From motility to virulence: Sensing and responding to environmental signals in Vibrio cholerae. Curr Opin Microbiol 2003;6: 186-190.
27. Jamet A, Rousseau C, Monfort JB, Frapy E, Nassif X, Martin P: A two-component system is required for colonization of host cells by meningococcus. Microbiology (Reading, England) 2009;155(Pt 7): 2288-2295.
28. Holland IB, Schmitt L, Young J: Type 1 protein secretion in bacteria, the ABC-transporter dependent pathway. Mol Membr Biol 2005;22:29-39.
29. Kerr JR: Gram-negative bacterial protein secretion. J Infect 2000;40:121-126.
30. Hauser AR: The type III secretion system of Pseudomonas aeruginosa: Infection by injection. Nat Rev Microbiol 2009;7:654-665.
31. Backert S, Meyer TF: Type IV secretion systems and their effectors in bacterial pathogenesis. Curr Opin Microbiol 2006;9:207-217.
32. Bingle LE, Bailey CM, Pallen MJ: Type VI secretion: A beginner's guide. Curr Opin Microbiol 2008;11: 3-8.
33. Bassler BL, Losick R: Bacterially speaking. Cell 2006;125:237-246.
34. Bassler BL: Small talk: Cell-to-cell communication in bacteria. Cell 2002;109:421-424.
35. Winzer K, Sun YH, Green A, Delory M, Blackley D, Hardle KR, Baldwin TJ, Tang CM: Role of Neisseria meningitidis luxS in cell-to-cell signaling and bacteremic infection. Infect Immun 2002;70:2245-2248.
36. Dove JE, Yasukawa K, Tinsley CR, Nassif X: Production of the signalling molecule, autoinducer-2, by Neisseria meningitidis: Lack of evidence for a concerted transcriptional response. Microbiology 2003;149:1859-1869.
37. Donlan RM, Costerton JW: Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002;15:167-193.
38. Sim RJ, Harrison MM, Moxon ER, Tang CM: Underestimation of meningococci in tonsillar tissue by nasopharyngeal swabbing. Lancet 2000;356: 1653-1654.
39. Neil RB, Shao JQ, Apicella MA: Biofilm formation on human airway epithelia by encapsulated Neisseria meningitidis serogroup B. Microbes Infect 2009;11: 281-287.
40. Yi K, Rasmussen AW, Gudlavalleti SK, Stephens DS, Stojiljkovic I: Biofilm formation by Neisseria meningitidis. Infect Immun 2004;72:6132-6138.
41. Lukacova M, Barak I, Kazar J: Role of structural variations of polysaccharide antigens in the pathogenicity of Gram-negative bacteria. Clin Microbiol Infect 2008;14:200-206.
42. Cartwright KA, Stuart JM, Jones DM, Noah ND: The Stonehouse survey: Nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol Infect 1987;99:591-601.
43. Strateva T, Yordanov D: Pseudomonas aeruginosa -a phenomenon of bacterial resistance. J Med Microbiol 2009;58:1133-1148.
44. Pitout JD: Multiresistant Enterobacteriaceae: New threat of an old problem. Expert Rev Anti Infect Ther 2008;6:657-669.